Pharmaceuticals and personal care products found in the Great Lakes above concentrations of environmental concern

Al Aukidy, 2012, Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy, Sci. Total Environ., 438, 15, 10.1016/j.scitotenv.2012.08.061 Aydin, 2013, Analysis, occurrence and fate of commonly used pharmaceuticals and hormones in the Buyukcekmece Watershed, Turkey, Chemosphere, 90, 2004, 10.1016/j.chemosphere.2012.10.074 Benotti, 2009, Pharmaceuticals and endocrine disrupting compounds in US drinking water, Environ. Sci. Technol., 43, 597, 10.1021/es801845a Blair, 2013, Evaluation of a model for the removal of pharmaceuticals, personal care products, and hormones from wastewater, Sci. Total Environ., 444C, 515, 10.1016/j.scitotenv.2012.11.103 Beeton, 2002, Large freshwater lakes: present state, trends, and future, Environ. Conserv., 29, 21, 10.1017/S0376892902000036 Brodin, 2013, Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations, Science, 339, 814, 10.1126/science.1226850 Brooks, 2003, Aquatic ecotoxicology of fluoxetine, Toxicol. Lett., 142, 169, 10.1016/S0378-4274(03)00066-3 Cahill, 2004, Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry, J. Chromatogr. A, 1041, 171, 10.1016/j.chroma.2004.04.005 Christensen, 2009, Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges, Chemosphere, 77, 351, 10.1016/j.chemosphere.2009.07.018 Csiszar, 2011, Aquivalence revisited – new model formulation and application to assess environmental fate of ionic pharmaceuticals in Hamilton Harbour, Lake Ontario, Environ. Int., 37, 821, 10.1016/j.envint.2011.02.001 Dickenson, 2011, Indicator compounds for assessment of wastewater effluent contributions to flow and water quality, Water Res., 45, 1199, 10.1016/j.watres.2010.11.012 Esperanza, 2007, Fate of sex hormones in two pilot-scale municipal wastewater treatment plants: conventional treatment, Chemosphere, 66, 1535, 10.1016/j.chemosphere.2006.08.020 Fent, 2006, Ecotoxicology of human pharmaceuticals, Aquat. Toxicol., 76, 122, 10.1016/j.aquatox.2005.09.009 Focazio, 2008, A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States – II) untreated drinking water sources, Sci. Total Environ., 402, 201, 10.1016/j.scitotenv.2008.02.021 Glassmeyer, 2005, Transport of chemical and microbial compounds from known wastewater discharges: Potential for use as indicators of human fecal contamination, Environ. Sci. Technol., 39, 5157, 10.1021/es048120k Gomez, 2007, Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast, Chemosphere, 66, 993, 10.1016/j.chemosphere.2006.07.051 Gros, 2010, Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes, Environ. Int., 36, 15, 10.1016/j.envint.2009.09.002 Halling-Sorensen, 1998, Occurrence, fate and effects of pharmaceutical substances in the environment – a review, Chemosphere, 36, 357, 10.1016/S0045-6535(97)00354-8 Han, 2006, Ecotoxicological risk of pharmaceuticals from wastewater treatment plants in Korea: occurrence and toxicity to Daphnia magna, Environ. Toxicol. Chem., 25, 265, 10.1897/05-193R.1 Hernando, 2006, Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments, Talanta, 69, 334, 10.1016/j.talanta.2005.09.037 Huerta-Fontela, 2011, Occurrence and removal of pharmaceuticals and hormones through drinking water treatment, Water Res., 45, 1432, 10.1016/j.watres.2010.10.036 Joss, 2006, Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme, Water Res., 40, 1686, 10.1016/j.watres.2006.02.014 Kolpin, 2002, Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999–2000: a national reconnaissance, Environ. Sci. Technol., 36, 1202, 10.1021/es011055j Kümmerer, 2009, Antibiotics in the aquatic environment – a review – Part I, Chemosphere, 75, 417, 10.1016/j.chemosphere.2008.11.086 Larsson, 2007, Effluent from drug manufactures contains extremely high levels of pharmaceuticals, J. Hazard. Mater., 148, 751, 10.1016/j.jhazmat.2007.07.008 Loranzo, 2013, Fate of triclocarban, triclosan and methyltriclosan during wastewater and biosolids treatment processes, Water Res., 47, 4519, 10.1016/j.watres.2013.05.015 Li, 2010, Sampling in the Great Lakes for pharmaceutical, personal care products, and endcrine-disrupting substances using the passive polar organic chemical integrative sampler, Environ. Toxicol. Chem., 29, 751, 10.1002/etc.104 Metcalfe, 2003, Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada, Environ. Toxicol. Chem., 22, 2881, 10.1897/02-627 Miege, 2009, Fate of pharmaceuticals and personal care products in wastewater treatment plants – conception of a database and first results, Environ. Pollut., 157, 1721, 10.1016/j.envpol.2008.11.045 Newton, 2011, Lachnospiraceae and bacteroidales alternative fecal indicators reveal chronic human sewage contamination in an urban harbor, Appl. Environ. Microbiol., 77, 6972, 10.1128/AEM.05480-11 Oosterhuis, 2013, Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data, Sci. Total Environ., 442, 380, 10.1016/j.scitotenv.2012.10.046 Oulton, 2010, Pharmaceuticals and personal care products in effluent matrices: a survey of transformation and removal during wastewater treatment and implications for wastewater management, J. Environ. Monit., 12, 1956, 10.1039/c0em00068j Phillips, 2010, Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents, Environ. Sci. Technol., 44, 4910, 10.1021/es100356f Radjenovic, 2009, Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment, Water Res., 43, 831, 10.1016/j.watres.2008.11.043 Rao, 2007, Transport and mixing between the coastal and offshore waters in the Great Lakes: a review, J. Great Lakes Res., 33, 202, 10.3394/0380-1330(2007)33[202:TAMBTC]2.0.CO;2 Rosal, 2010, Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation, Water Res., 44, 578, 10.1016/j.watres.2009.07.004 Santos, 2007, Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain), Environ. Int., 33, 596, 10.1016/j.envint.2006.09.014 Scheurer, 2009, Occurrence of the antidiabetic drug metformin in sewage and surface waters in Germany, J. Environ. Monit., 11, 1608, 10.1039/b909311g Scheurer, 2012, Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment, Water Res., 46, 4790, 10.1016/j.watres.2012.06.019 Snyder, 2008, Occurrence, treatment, and toxicological relevance of EDCs and pharmaceuticals in water, Ozone-Sci. Eng., 30, 65, 10.1080/01919510701799278 Suarez, 2012, Mass balance of pharmaceutical and personal care products in a pilot-scale single-sludge system: Influence of T, SRT and recirculation ratio, Chemosphere, 89, 164, 10.1016/j.chemosphere.2012.05.094 Ternes, 1998, Occurrence of drugs in German sewage treatment plants and rivers, Water Res., 32, 3245, 10.1016/S0043-1354(98)00099-2 Tewari, 2013, Major pharmaceutical residues in wastewater treatment plants and receiving waters in Bangkok, Thailand, and associated ecological risks, Chemosphere, 91, 697, 10.1016/j.chemosphere.2012.12.042 Trautwein, 2011, Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea, Chemosphere, 85, 765, 10.1016/j.chemosphere.2011.06.057 USEPA, 2012a. Great Lakes Basic Information. <http://www.epa.gov/glnpo/basicinfo.html>. USEPA, 2012b. Ecological Structure Activity Relationship (ECOSAR). <http://www.epa.gov/oppt/newchems/tools/21ecosar.htm>. USEPA, 2007a. Method 1694: Pharmaceuticals and Personal Care Products in Water, Soil, Sediment, and Biosolids by HPLC/MS/MS. USEPA, 2007b. Method 1698: Steroids and Hormones in Water, Soil, Sediment, and Biosolids by HRGC/HRMS. Valcarcel, 2011, Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk, Chemosphere, 84, 1336, 10.1016/j.chemosphere.2011.05.014 Verlicchi, 2012, Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment-a review, Sci. Total Environ., 429, 123, 10.1016/j.scitotenv.2012.04.028 Vieno, 2007, Elimination of pharmaceuticals in sewage treatment plants in Finland, Water Res., 41, 1001, 10.1016/j.watres.2006.12.017 Yamamoto, 2009, Persistence and partitioning of eight selected pharmaceuticals in the aquatic environment: laboratory photolysis, biodegradation, and sorption experiments, Water Res., 43, 351, 10.1016/j.watres.2008.10.039 Yu, 2009, Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee, USA, Chemosphere, 75, 1281, 10.1016/j.chemosphere.2009.03.043 Yu, 2013, Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants, Sci. Total Environ., 442, 310, 10.1016/j.scitotenv.2012.10.001 Wu, 2009, Occurrence of selected pharmaceuticals in an agricultural landscape, western Lake Erie basin, Water Res., 43, 3407, 10.1016/j.watres.2009.05.014